clopidogrel 75 mg
1 INDICATIONS AND USAGE Clopidogrel tablet is a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome - For patients with non-ST-segment elevation ACS (unstable angina [UA]/non- ST-elevation myocardial infarction [NSTEMI]), Plavix has been shown to reduce the rate of myocardial infarction (MI) and stroke. ( 1.1 ) - For patients with ST-elevation myocardial infarction (STEMI), Plavix has been shown to reduce the rate of MI and stroke. ( 1.1 ) Recent MI, recent stroke, or established peripheral arterial disease. Clopidogrel has been shown to reduce the rate of MI and stroke. ( 1.2 ) 1.1 Acute Coronary Syndrome (ACS) Clopidogrel tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those who are to be managed with coronary revascularization. Clopidogrel tablets should be administered in conjunction with aspirin. Clopidogrel tablet is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI) who are to be managed medically. Clopidogrel tablets should be administered in conjunction with aspirin. 1.2 Recent MI, Recent Stroke, or Established Peripheral Arterial Disease In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Clopidogrel tablet is indicated to reduce the rate of MI and stroke.
viona pharmaceuticals inc
ROUND PINK 379
379 ROUND PINK
Related Pills
Indomethacin 75 MG Extended Release Oral Capsule
Jubilant Cadista Pharmaceuticals Inc.
ranolazine tablet 1000 mg film coated extended release
amneal pharmaceuticals llc
dexmethylphenidate hydrochloride tablet
sun pharmaceutical industries, inc.
dexmethylphenidate hydrochloride tablet
sun pharmaceutical industries, inc.
ezetimibe 10 mg
ScieGen Pharmaceuticals Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
CLOPIDOGREL tablets, USP equivalent to 75 mg of
CLOPIDOGREL are pink-colored, biconvex, round-shaped, film-coated tablets debossed with '379' on one side and plain on the other side and are supplied as follows: NDC 72578-012-06 in bottle of 30 tablets NDC 72578-012-16 in bottle of 90 tablets NDC 72578-012-05 in bottle of 500 tablets NDC 72578-012-10 in bottle of 1,000 tablets Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.
More pills like ROUND 379